PlainPharmaWatch

CMS Open Payments · Program Year 2024

Atland Pharmaceuticals, LLC

Atland Pharmaceuticals, LLC reported $6,967.54 across General Payments, Research, and Ownership to 220 physicians and teaching hospitals across 220 transactions.

See the rankings → How this is sourced
$7.0K
All-tracks total
220
Transactions
220
Recipients
#1681
of 1,925 companies

Atland Pharmaceuticals, LLC reported $6,967.54 across all CMS Open Payments tracks (General + Research + Ownership) to 220 physicians and teaching hospitals in Program Year 2024 - ranking #1681 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $6,967.54, averaging $31.67 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer atland-pharmaceuticals-llc Atland Pharmaceuticals, LLC

$7.0K · #1681/1,925 · 0.0% industry · PY2024

  • TOT $7.0K
  • RANK #1681
  • SHARE 0.0%
  • TXN 220
  • RCP 220
  • CAT 2
  • GEN $7.0K
  • TOP1 8.8%
  • PY 2024

Volume peers

Nearest volume peer: Nonin Medical, Inc. ($7.0K)

Epien Medical, Inc.$7.0KAtland Pharmaceuticals, LLC …$7.0KNonin Medical, Inc.$7.0KSpirus Medical LLC$6.9KVisionRT, Inc.$6.9K
All-tracks payment totals near Atland Pharmaceuticals, LLC (CMS Open Payments PY2024)

Atland Pharmaceuticals, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Atland Pharmaceuticals, LLC

Atland Pharmaceuticals, LLC ranks #1681 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $6,967.54 across 220 transactions to 220 physicians and teaching hospitals - $31.67 per transaction and $31.67 per recipient on average.

The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $5.0K, accounting for 71.3% of this company's General Payments and 216 transactions.

General Payment Breakdown by Type

"Food and Beverage" leads Atland Pharmaceuticals, LLC's 2-category general-payment breakdown at $5.0K, 71.3% of the reported total.

How Atland Pharmaceuticals, LLC divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$5.0K2. Compensation for Services…$2.0K
Payment Type Amount Transactions
Food and Beverage $5.0K 216
Compensation for Services Other Than Consulting $2.0K 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $2,310.42 (33.2%) of $6,967.54 in this company's General Payments records across 125 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Atland Pharmaceuticals, LLC

The five named recipients with the highest reported General Payments from this company

Brandi Meads$614.16Johnny Young$548.48James Thacker$500.00Bryan King$500.00Haley Gibbs$147.78
  1. 1

    Brandi Meads

    $614.16 across 8 reported transactions

  2. 2

    Johnny Young

    $548.48 across 4 reported transactions

  3. 3

    James Thacker

    $500.00 across 1 reported transactions

  4. 4

    Bryan King

    $500.00 across 1 reported transactions

  5. 5

    Haley Gibbs

    $147.78 across 10 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Atland Pharmaceuticals, LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Atland Pharmaceuticals, LLC.

Avanos Medical

HHI 298

Melinta Therapeutics, LLC

HHI 300

Paratek Pharmaceuticals, Inc.

HHI 302

Synthes USA Products LLC

HHI 302

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Atland Pharmaceuticals, LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Atland Pharmaceuticals, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.